| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.18 | 0.003 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.093 | 0.004 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.15 | 0.006 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.16 | 0.006 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |